Nocebo effects: more investigation is needed (English)
- New search for: Benedetti, Fabrizio
- New search for: Shaibani, Aziz
- New search for: Benedetti, Fabrizio
- New search for: Shaibani, Aziz
In:
Expert Opinion on Drug Safety
;
17
, 6
;
541-543
;
2018
- Article (Journal) / Electronic Resource
-
Title:Nocebo effects: more investigation is needed
-
Contributors:Benedetti, Fabrizio ( author ) / Shaibani, Aziz ( author )
-
Published in:Expert Opinion on Drug Safety ; 17, 6 ; 541-543
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2018-06-03
-
Size:3 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 17, Issue 6
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 537
-
How to address the placebo response in the prescription SSRIs and SNRIs in children and adolescentsKoechlin, Helen / Kossowsky, Joe / Gaab, Jens / Locher, Cosima et al. | 2018
- 541
-
Nocebo effects: more investigation is neededBenedetti, Fabrizio / Shaibani, Aziz et al. | 2018
- 545
-
A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) databaseDagenais, Simon / Scranton, Richard / Joyce, Andrew R. / Vick, Catherine C. et al. | 2018
- 553
-
Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicitiesGonzález, Julieta / Quiroga, Matías / Escudero-Vilaplana, Vicente / Collado-Borrell, Roberto / Herranz-Alonso, Ana / Sanjurjo Sáez, María et al. | 2018
- 573
-
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studiesCastellano, Daniel / Maroto, José Pablo / Espinosa, Enrique / Grande, Enrique / Bolós, M Victoria / Llinares, Julia / Esteban, Emilio / González del Alba, Aranzazu / Climent, Miguel Angel / Arranz, Jose Angel et al. | 2018
- 581
-
Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluationAggarwal, Nitish et al. | 2018
- 589
-
The safety of dual bronchodilation on cardiovascular serious adverse events in COPDRogliani, Paola / Ora, Josuel / Matera, Maria Gabriella / Cazzola, Mario / Calzetta, Luigino et al. | 2018
- 597
-
Current and potential treatment options for hyperphosphatemiaCarfagna, Fabio / Del Vecchio, Lucia / Pontoriero, Giuseppe / Locatelli, Francesco et al. | 2018
- 609
-
A safety profile of medications used to treat Waldenström’s macroglobulinemiaGarcía-Sanz, Ramón / Jiménez, Cristina / González De La Calle, Verónica / Sarasquete, María Eugenia et al. | 2018
- 623
-
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinibBreccia, Massimo / Efficace, Fabio / Iurlo, Alessandra / Luciano, Luigiana / Abruzzese, Elisabetta / Gozzini, Antonella / Pregno, Patrizia / Tiribelli, Mario / Rosti, Gianantonio / Minotti, Giorgio et al. | 2018
- 629
-
Analyzing research trends on drug safety using topic modelingZou, Chen et al. | 2018
- 637
-
The safety of indacaterol for the treatment of COPDMetaxas, Evgenios I. / Balis, Evangelos et al. | 2018
- 643
-
The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancerMartinez-Perez, Julia / Riesco-Martinez, M. Carmen / Garcia-Carbonero, Rocio et al. | 2018
- 651
-
Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategiesOng, Gary / Manyak, Michael / Lulic, Zrinka et al. | 2018
- 653
-
Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategiesMotofei, Ion G. / Rowland, David L. et al. | 2018
- 655
-
Addendum| 2018